News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Xcellerex, Inc. Appoints David J. Williams, Retired Chairman/CEO of Sanofi Pasteur, to its Board of Directors
April 1, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Xcellerex, Inc. today announced that it has named David J. Williams, retired Chairman and CEO of Sanofi Pasteur, S.A., the vaccines business of sanofi-aventis Group, to its board of directors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Earnings
Novartis CEO Brushes Off Tariffs but Says Trump Pricing Controls Would Be ‘Devastating’
April 29, 2025
·
3 min read
·
Annalee Armstrong
Pipeline
AstraZeneca Abandons Neuroscience, Prioritizes Weight Loss, Immunology
April 29, 2025
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Biohaven Grabs a Foothold With $600M Windfall From Oberland Capital
April 29, 2025
·
2 min read
·
Tristan Manalac
Earnings
Regeneron Shares Tumble as Eylea Declines Make for a ‘Messy Quarter’ To Come
April 29, 2025
·
1 min read
·
Annalee Armstrong